FOCAL EPILEPSY
Clinical trials for FOCAL EPILEPSY explained in plain language.
Never miss a new study
Get alerted when new FOCAL EPILEPSY trials appear
Sign up with your email to follow new studies for FOCAL EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame seizures in Drug-Resistant epilepsy
Disease control OngoingThis study tests whether a daily pill called BHV-7000 can reduce seizures in adults with refractory focal epilepsy—a type of epilepsy that doesn't respond well to current medications. About 390 participants will receive either a low dose, a higher dose, or a placebo for 8 weeks. …
Matched conditions: FOCAL EPILEPSY
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Brain implant study tests new epilepsy drug
Disease control OngoingThis early-phase study tested a new drug called BHV-7000 in 5 people with epilepsy who have a brain implant (RNS) that records brain activity. The goal was to see if the drug reduces abnormal electrical activity linked to seizures. Participants took the drug for 4 weeks, and thei…
Matched conditions: FOCAL EPILEPSY
Phase: PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New epilepsy drug XEN1101 tested for long-term seizure control
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …
Matched conditions: FOCAL EPILEPSY
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New epilepsy drug safety check: 660 patients monitored long-term
Disease control ENROLLING_BY_INVITATIONThis study checks the long-term safety of the drug BHV-7000 in about 660 adults whose focal epilepsy has not been controlled by other treatments. Participants who completed an earlier study will continue taking the drug while doctors watch for side effects and lab changes. The go…
Matched conditions: FOCAL EPILEPSY
Phase: PHASE2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Glasses that see seizures coming: new wearable aims to predict epilepsy attacks
Symptom relief OngoingThis study tests a pair of smart glasses called NEXA that can read brain signals through dry electrodes. The glasses aim to predict epileptic seizures in real time and alert the wearer with vibrations, lights, or sounds. Researchers will test the device on 47 adults with epilepsy…
Matched conditions: FOCAL EPILEPSY
Phase: NA • Sponsor: Oman Ministry of Health • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Brain chip tracks seizures in real time – could it stop them?
Knowledge-focused OngoingThis study tests a brain implant that records brain activity and can deliver small electrical pulses to prevent seizures in people with epilepsy. Five participants will use the device along with a handheld tool to track mood, anxiety, and thinking. The main goal is to see if the …
Matched conditions: FOCAL EPILEPSY
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC